Literature DB >> 33667241

Control strategies for COVID-19 epidemic with vaccination, shield immunity and quarantine: A metric temporal logic approach.

Zhe Xu1, Bo Wu2, Ufuk Topcu2,3.   

Abstract

Ever since the outbreak of the COVID-19 epidemic, various public health control strategies have been proposed and tested against the coronavirus SARS-CoV-2. We study three specific COVID-19 epidemic control models: the susceptible, exposed, infectious, recovered (SEIR) model with vaccination control; the SEIR model with shield immunity control; and the susceptible, un-quarantined infected, quarantined infected, confirmed infected (SUQC) model with quarantine control. We express the control requirement in metric temporal logic (MTL) formulas (a type of formal specification languages) which can specify the expected control outcomes such as "the deaths from the infection should never exceed one thousand per day within the next three months" or "the population immune from the disease should eventually exceed 200 thousand within the next 100 to 120 days". We then develop methods for synthesizing control strategies with MTL specifications. To the best of our knowledge, this is the first paper to systematically synthesize control strategies based on the COVID-19 epidemic models with formal specifications. We provide simulation results in three different case studies: vaccination control for the COVID-19 epidemic with model parameters estimated from data in Lombardy, Italy; shield immunity control for the COVID-19 epidemic with model parameters estimated from data in Lombardy, Italy; and quarantine control for the COVID-19 epidemic with model parameters estimated from data in Wuhan, China. The results show that the proposed synthesis approach can generate control inputs such that the time-varying numbers of individuals in each category (e.g., infectious, immune) satisfy the MTL specifications. The results also show that early intervention is essential in mitigating the spread of COVID-19, and more control effort is needed for more stringent MTL specifications. For example, based on the model in Lombardy, Italy, achieving less than 100 deaths per day and 10000 total deaths within 100 days requires 441.7% more vaccination control effort than achieving less than 1000 deaths per day and 50000 total deaths within 100 days.

Entities:  

Year:  2021        PMID: 33667241     DOI: 10.1371/journal.pone.0247660

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  6 in total

1.  Age structure in SIRD models for the COVID-19 pandemic-A case study on Italy data and effects on mortality.

Authors:  Giuseppe Carlo Calafiore; Giulia Fracastoro
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.240

2.  Analysis of COVID-19 Risk Following a Ring Vaccination Intervention to Address SARS-CoV-2 Alpha Variant Transmission in Montreal, Canada.

Authors:  Simone Périnet; Geneviève Cadieux; Sarah-Amélie Mercure; Mylène Drouin; Robert Allard
Journal:  JAMA Netw Open       Date:  2022-02-01

3.  Mathematical Modeling and Control of COVID-19 Using Super Twisting Sliding Mode and Nonlinear Techniques.

Authors:  Anwer S Aljuboury; Firas Abedi; Hanan M Shukur; Zahraa Sabah Hashim; Ibraheem Kasim Ibraheem; Ahmed Alkhayyat
Journal:  Comput Intell Neurosci       Date:  2022-06-30

4.  Effects of Vaccination and the Spatio-Temporal Diffusion of Covid-19 Incidence in Turkey.

Authors:  Firat Bilgel; Burhan Can Karahasan
Journal:  Geogr Anal       Date:  2022-06-04

5.  Adaptive SIR model with vaccination: simultaneous identification of rates and functions illustrated with COVID-19.

Authors:  Tchavdar T Marinov; Rossitza S Marinova
Journal:  Sci Rep       Date:  2022-09-20       Impact factor: 4.996

6.  Multiscale heterogeneous optimal lockdown control for COVID-19 using geographic information.

Authors:  Cyrus Neary; Murat Cubuktepe; Niklas Lauffer; Xueting Jin; Alexander J Phillips; Zhe Xu; Daoqin Tong; Ufuk Topcu
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.